药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Gusperimus
The risk or severity of adverse effects can be increased when Gusperimus is combined with Tetrandrine.
3-Methylfentanyl
Mizoribine
The risk or severity of adverse effects can be increased when Mizoribine is combined with Tetrandrine.
3-Methylfentanyl
Triptolide
The risk or severity of adverse effects can be increased when Triptolide is combined with Tetrandrine.
3-Methylfentanyl
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Tetrandrine.
3-Methylfentanyl
Guselkumab
The risk or severity of adverse effects can be increased when Guselkumab is combined with Tetrandrine.
3-Methylfentanyl
Sirukumab
The risk or severity of adverse effects can be increased when Sirukumab is combined with Tetrandrine.
3-Methylfentanyl
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Tetrandrine.
3-Methylfentanyl
Sarilumab
The risk or severity of adverse effects can be increased when Sarilumab is combined with Tetrandrine.
3-Methylfentanyl
Peficitinib
The risk or severity of adverse effects can be increased when Peficitinib is combined with Tetrandrine.
3-Methylfentanyl
Voclosporin
The risk or severity of adverse effects can be increased when Voclosporin is combined with Tetrandrine.
3-Methylfentanyl
Pirarubicin
The risk or severity of adverse effects can be increased when Pirarubicin is combined with Tetrandrine.
3-Methylfentanyl
Ravulizumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Tetrandrine.
3-Methylfentanyl
Ixekizumab
The risk or severity of adverse effects can be increased when Ixekizumab is combined with Tetrandrine.
3-Methylfentanyl
Melengestrol
The risk or severity of adverse effects can be increased when Melengestrol is combined with Tetrandrine.
3-Methylfentanyl
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Tetrandrine.
3-Methylfentanyl
Tepoxalin
The risk or severity of adverse effects can be increased when Tepoxalin is combined with Tetrandrine.
3-Methylfentanyl
Meprednisone
The risk or severity of adverse effects can be increased when Meprednisone is combined with Tetrandrine.
3-Methylfentanyl
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Tetrandrine.
3-Methylfentanyl
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Tetrandrine.
3-Methylfentanyl
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Tetrandrine.